8-Bromo-9-(b-D-xylofuranosyl)guanine

CAS: 1212650-12-8

Ref. 3D-NB163092

Produktinformation

• Name: 8-Bromo-9-(b-D-xylofuranosyl)guanine
• CAS: 1212650-12-8

Beschreibung

8-Bromo-9-(beta-D-xylofuranosyl)guanine (8BrG) is a modified nucleoside that has been shown to inhibit DNA and RNA synthesis in cells. This compound is also an antiviral agent with activity against herpes simplex virus type 1, herpes simplex virus type 2, and HIV. 8BrG inhibits the production of viral diphosphate and ribonucleosides by competitive inhibition of cellular enzymes involved in nucleotide biosynthesis. 8BrG is not active against bacterial cells, which lack these enzymes. 8BrG is synthesized by the addition of a bromine to the 9th position of guanine. It is a novel nucleotide that may have applications as an activator for other drugs or as a cancer treatment.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 362.14 g/mol
• Formel: C₁₀H₁₂BrN₅O₅
• Reinheit: Min. 95%